文献速递妇科

妇科肿瘤手术后静脉血栓栓塞症发生率低:谁的风险最高?

Low incidence of venous thromboembolism after gynecologic oncology surgery: Who is at greatest risk?
PubMed 文献 · Gynecol Oncol · 2021-12-16

基于ACS-NSQIP数据库2013至2019年63198例妇科肿瘤手术患者,术后30天静脉血栓栓塞症(VTE)发生率为1.2%。多因素分析显示腹水、播散性癌症、术前白蛋白<30 g/L、开腹手术、手术时间>180分钟和手术复杂度增加与VTE显著相关。开腹手术VTE发生率高于微创手术(2.3% vs 0.6%)。

要点

  • 妇科肿瘤手术后30天VTE发生率为1.2%(n=781)。
  • 开腹手术VTE发生率2.3%,高于微创手术的0.6%。
  • 腹水、播散性癌症、术前白蛋白<30 g/L、开腹、手术时间>180分钟及手术复杂度增加是VTE危险因素。

核心结论

  • 术后VTE是妇科肿瘤手术可潜在预防的并发症,开腹手术、腹水、播散性癌症、较长手术时间和术前低白蛋白是VTE的危险因素。

研究设计与样本

  • 查询美国外科医师学会国家手术质量改进计划(ACS-NSQIP)数据库,纳入2013至2019年所有妇科肿瘤病例,共63198例患者。

主要发现

  • 术后30天VTE发生率为1.2%(n=781)。
  • 多因素分析显示VTE与腹水(OR 1.8)、播散性癌症(OR 1.7)、术前白蛋白<30 g/L(OR 1.9)、开腹手术(OR 2.8)、手术时间>180分钟(OR 2.0)及手术复杂度增加(OR 2.2)显著相关(均p<0.001)。
  • 开腹手术VTE发生率2.3%,高于微创手术的0.6%(p<0.001)。
  • 开腹手术中,卵巢癌(2.4%)和子宫癌(2.4%)患者VTE发生率高于宫颈癌(1.1%)(p<0.001)。
  • 30天VTE发生率2013年为1.7%,2019年为0.9%(开腹手术:2013年2.6%至2019年1.6%;微创手术:2013年0.8%至2019年0.4%)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine the 30-day incidence of venous thromboembolism (VTE) after gynecologic oncologic surgery and identify perioperative factors associated with postoperative VTE. METHODS: The American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) database was queried to identify all gynecologic oncology cases from 2013 to 2019. Clinical and surgical characteristics, VTE events and 30-day postoperative complications were retrieved. Chi-square analysis and logistic regression models were performed to compare characteristics and postoperative outcomes of patients with and without VTE. RESULTS: A total of 63,198 gynecologic oncology patients were included. The incidence of 30-day postoperative VTE was 1.2% (n = 781). On multivariable analysis, postoperative VTE was significantly associated with ascites (odds ratio (OR) 1.8), disseminated cancer (OR 1.7), pre-operative albumin <30 g/L (OR 1.9), laparotomy (OR 2.8), operative time > 180 min (OR 2.0), and increased surgical complexity (OR 2.2) (all p < 0.001). The incidence of VTE was higher after laparotomy compared to minimally invasive surgery (MIS) (2.3% v. 0.6%, p < 0.001). When stratified by type of gynecologic malignancy undergoing laparotomy, incidence of VTE was higher in patients with ovarian (2.4%) and uterine (2.4%) malignancies, compared to cervical cancer (1.1%) (p < 0.001). The 30-day incidence of VTE was 1.7% in 2013 compared to 0.9% in 2019 (laparotomy: 2.6% in 2013 to 1.6% in 2019 and MIS: 0.8% in 2013 to 0.4% in 2019). CONCLUSION: Postoperative VTE is a potentially preventable complication of gynecologic oncology surgery. Our findings indicate that laparotomy, ascites, disseminated cancer, longer operative time, and low pre-operative albumin are risk factors for VTE.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Swift BE, Maeda A, Bouchard-Fortier G, et al. Low incidence of venous thromboembolism after gynecologic oncology surgery: Who is at greatest risk? Gynecol Oncol. 2021. PMID: 34920887. doi:10.1016/j.ygyno.2021.12.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。